TOSOH (4042) FY2027 Q1 Earnings Report

Quick View

Executive Summary

Tosoh posted increases in both revenue and earnings in Q1, with the operating margin expanding significantly due to a recovery in chemical product market conditions and an improved product mix. Revenue was ¥2,741.7B (+11.8% YoY), Operating Income was ¥311.8B (+93.9%), Ordinary Income was ¥343.0B (+143.6%), and consolidated Net Income was ¥219.8B (+148.4%). Revenue growth was driven by expansion across all segments, including Basic Materials, Value-Added Materials, and Water Treatment. The primary drivers of earnings growth were the turnaround to profitability in the Basic Materials segment, which had reported an operating loss in the previous year, and expansion in the high-margin Value-Added Materials and Bioscience businesses.

Factors Affecting Performance

【Revenue】All segments recorded higher revenue, resulting in broad-based top-line growth. Based on sales to external customers, Basic Materials was the largest segment at ¥1,248.3B (45.5% of total, +13.4% YoY), followed by Value-Added Materials at ¥428.6B (+13.9%) and Water Treatment Engineering at ¥419.8B (+9.5%). Bioscience was nearly flat at ¥154.4B (+0.2%), with slower growth than the other segments.

【Profit and Loss】Operating Income increased +93.9% to ¥311.8B. The gross margin improved by +4.1pt to 27.2% (23.1% in the previous year), while the operating margin improved by +4.8pt to 11.4% (6.6% in the previous year). The largest positive factor was the turnaround in Basic Materials’ operating results, from an operating loss of △¥33.9B in the previous year to profit of ¥56.6B in the current period. Value-Added Materials posted Operating Income of ¥82.0B (+109.1%), representing the largest contribution to segment earnings at 26.3% of total segment profit. Bioscience maintained high profitability, with a margin of 36.6%. Meanwhile, Water Treatment Engineering recorded lower earnings despite higher revenue, with Operating Income of ¥65.5B (-8.7%) and its margin declining from 18.7% to 15.5%, suggesting an impact from project mix. Ordinary Income grew faster than Operating Income, supported by non-operating income including foreign exchange gains of ¥16.6B and dividend income of ¥8.9B. Consolidated Net Income increased +148.4% despite absorbing extraordinary losses of ¥11.5B, primarily losses on disposal of fixed assets of ¥11.2B, leading to the conclusion that the company achieved both revenue and earnings growth.

Segment Analysis

The composition of segment profit (totaling ¥311.8B) was as follows: Value-Added Materials at ¥82.0B (26.3% of total, YoY+109.1%), Water Treatment Engineering at ¥65.5B (21.0%, YoY-8.7%), Bioscience at ¥57.4B (18.4%, YoY+24.0%), Basic Materials at ¥56.6B (18.2%, a turnaround from an operating loss in the previous year), High-Performance Materials at ¥31.7B (10.2%, YoY+29.1%), and Other at ¥18.6B (6.0%, YoY+45.2%).

Basic Materials made the largest contribution to earnings growth, as the segment turned profitable on higher revenue of +13.4% and improved profitability. Value-Added Materials and Bioscience are relatively high-margin businesses, with margins of 15.8% and 36.6%, respectively, and drove earnings growth. Water Treatment Engineering was the only segment to report lower earnings. The decline in its margin from 18.7% to 15.5% despite higher revenue suggests variability in project profitability, which will be subject to monitoring going forward.

Key Financial Metrics

【Profitability】The operating margin improved by +4.8pt to 11.4% from 6.6% in the previous year. The gross margin also expanded by +4.1pt to 27.2% from 23.1%, while the consolidated net profit margin improved by +4.4pt to 8.0% from 3.6%. ROE was 2.4% (quarterly, non-annualized), exceeding 0.96% in the previous year, indicating that the recovery in profitability is being reflected in return metrics.【Cash Flow Quality】Operating Cash Flow (OCF) remained at only ¥3.6B, representing just 0.02x consolidated Net Income of ¥219.8B, an exceptionally low level that indicates a delay in cash conversion.【Investment Efficiency】Although the total asset turnover ratio improved slightly to 0.187x from 0.174x in the previous year, it remained low. ROA, based on consolidated Net Income, increased to 1.50% from 0.63%.【Financial Soundness】The Equity Ratio was 63.2%, down -2.0pt from 65.2% in the previous year. Short-term borrowings increased to ¥1,861.2B (+28.6% YoY), while the current ratio remained strong at 213%, indicating ample short-term liquidity.

Cash Flow Analysis

Cash flow from operating activities was ¥3.6B, a substantial decline of -99.0% from ¥365.1B in the previous year. Working capital was the primary factor: an increase in inventories resulted in a cash outflow of ¥107.2B, while an increase in trade receivables resulted in a cash outflow of ¥131.4B. Income taxes paid of ¥167.6B also weighed on cash flow. Cash flow from investing activities was -¥199.6B, reflecting continued investment in property, plant and equipment. Free Cash Flow was -¥196.0B (OCF of ¥3.6B + investing cash flow of -¥199.6B). Cash flow from financing activities was +¥315.6B, primarily supplementing funding requirements through additional short-term borrowings. Whether the accumulation of inventories and accounts receivable accompanying revenue growth is temporary or structural will depend on the degree of normalization observed in subsequent quarters.

Earnings Quality

The gap between Ordinary Income of ¥343.0B and consolidated Net Income of ¥219.8B reflects income taxes of ¥112.0B and Net Income attributable to non-controlling interests of ¥25.2B. The impact of extraordinary gains and losses—extraordinary gains of ¥0.2B and extraordinary losses of ¥11.5B—was limited. Of non-operating income of ¥46.8B, foreign exchange gains of ¥16.6B are dependent on market fluctuations, while dividend income of ¥8.9B represents relatively stable earnings. Comprehensive Income of ¥276.8B exceeded consolidated Net Income of ¥219.8B by ¥57.0B. The primary factors behind this difference were valuation differences on securities of +¥40.7B, foreign currency translation adjustments of +¥14.7B, and equity-method OCI of +¥8.8B, reflecting changes in asset values exceeding the earnings power of the underlying business. Meanwhile, OCF was extremely low relative to Net Income at ¥3.6B. The fact that accrual-related factors, namely increases in inventories and accounts receivable, delayed the conversion of earnings into cash is an important consideration in assessing earnings quality.

Earnings Forecasts and Guidance

The Q1 progress rates against the company’s full-year forecast—Revenue of ¥11,700.0B, Operating Income of ¥1,050.0B, and Ordinary Income of ¥1,070.0B—were 23.4%, 29.7%, and 32.1%, respectively. All profit metrics were progressing at a pace above the simple 25% benchmark. Progress against the full-year forecast for Net Income attributable to shareholders of the parent company of ¥590.0B was also ahead at 33.0%, indicating that earnings were progressing above plan as of Q1. The company revised its earnings forecast during the quarter, while no revision was made to its dividend forecast.

Shareholder Returns

The company’s full-year dividend forecast is ¥100 per share, double the ¥50 full-year dividend forecast as of the same period of the previous year. The Payout Ratio against forecast EPS of ¥191.63 is approximately 52.2%, representing a dividend increase plan accompanied by earnings growth. Meanwhile, Q1 Free Cash Flow was -¥196.0B and actual dividend payments were ¥154.1B. The dividend for the current period was not fully covered by internally generated funds, with funding through increased short-term borrowings serving as the effective source of funds. Given that full-year Operating Income is progressing above plan, the outlook for securing funds for dividends as of the fiscal year-end appears relatively favorable.

Risk Factors

1. Cash Conversion Risk: OCF was ¥3.6B, representing only 0.02x Net Income of ¥219.8B, an extremely low level. The primary factors were increases of +¥107.2B in inventories and +¥131.4B in trade receivables. If this situation continues, the deficit in Free Cash Flow could become structural.

2. Variability in Segment Profitability: Water Treatment Engineering recorded lower Operating Income of -8.7% despite higher revenue (+10.5%), with its margin declining from 18.7% to 15.5%. Basic Materials’ margin was also 3.9%, below the company-wide average of 11.4%, indicating earnings disparities within the portfolio.

3. Dependence on Short-Term Funding: Short-term borrowings increased to ¥1,861.2B (+28.6% YoY), and cash flow from financing activities was +¥315.6B. The company is covering the shortfall in Free Cash Flow and dividend payments through additional short-term liabilities, indicating a shortening of its funding structure.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The company is above the industry median, placing its profitability relatively high within the manufacturing sector.

Growth and Capital Efficiency

The revenue growth rate is significantly above the industry median and is in the high-growth range, close to the upper bound of the IQR.

※Source: Compiled by the Company

Key Takeaways from the Earnings Results

1. The turnaround to operating profitability in the Basic Materials segment was the primary driver of earnings growth, with the segment moving from an operating loss of △¥33.9B in the previous year to profit of ¥56.6B in the current period. Whether this turnaround reflects temporary cost and market condition factors or structural profitability improvements will be determined by the segment’s margin trends in subsequent quarters.

2. Value-Added Materials (15.8% margin) and Bioscience (36.6% margin) are high-margin segments that lifted the company-wide margin. Changes in the sales mix of these high-value-added areas will determine future margin levels.

3. The exceptionally low level of OCF relative to Net Income (0.02x) resulted from working capital factors, namely increases in inventories and accounts receivable. Whether these increases are temporary accumulations accompanying revenue growth or reflect a structural change in capital efficiency can be assessed through future trends in inventory and receivables turnover metrics.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson model with an explicit 5-year fade period). It is not a forecast of the market share price or a recommendation to take any specific investment action.

Sensitivity: ¥2,746–¥2,903 at Cost of Equity ±1%; ¥2,816–¥2,827 at ω±0.1.

Notes:

• Because forecast ROE is below the Cost of Equity, the theoretical value is below Book Value Per Share.
• Net assets as of the quarter-end are used; therefore, there is a timing difference relative to the full-year forecast.
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model / Interest Rate Reference Month: 2026-06 / This value is not a forecast or guarantee of the future share price)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Tosoh delivered a strong FY2027 Q1 profit recovery, led by a turnaround in Basic Materials and robust earnings in Value-added Materials. Revenue rose 11.8% year on year to ¥274.2bn, while operating income increased 93.9% to ¥31.2bn. The operating margin expanded by 480bp to 11.4% from 6.6% in the prior-year quarter. Gross profit rose 31.7% to ¥74.6bn and the gross margin increased by 400bp to 27.2%, indicating substantially improved pricing and/or product-mix absorption over production costs. SG&A increased 7.0% to ¥43.4bn, materially slower than revenue growth, creating favorable operating leverage. Ordinary income more than doubled, rising 143.6% to ¥34.3bn, aided by a ¥1.67bn foreign-exchange gain versus a foreign-exchange loss in the previous year. Profit attributable to owners of parent rose 198.0% to ¥19.5bn, equivalent to EPS of ¥63.19. Net margin expanded by 440bp to 7.1% from 2.7%. The Q1 annualized ROE was 8.4%, reflecting a meaningful recovery but remaining below the 10-15% level generally associated with a strong cost-of-equity return profile. The strongest segmental earnings driver was Value-added Materials, where segment profit rose 109.1% to ¥8.2bn. Basic Materials moved to a ¥5.7bn segment profit from a ¥3.4bn loss, providing the largest absolute year-on-year profit swing. Water Treatment Engineering remained a major profit contributor but segment profit declined 8.7% despite revenue growth, warranting monitoring. Cash generation was the principal negative: operating cash flow was only ¥0.4bn against ¥19.5bn of profit attributable to owners, as receivables, inventory and tax payments absorbed cash. Free cash flow was negative ¥19.6bn after ¥16.6bn of fixed-asset purchases, and financing cash flow of ¥31.6bn was supported principally by a ¥36.3bn increase in short-term borrowings. Full-year guidance implies Q1 progress of 23.4% for sales and 29.7% for operating income, placing operating profit modestly ahead of the normal 25% seasonal benchmark. The central investment implication is that operating recovery is credible at the segment level, but its durability should be confirmed through conversion of working capital into cash and stabilization of short-term funding reliance.

Profitability Analysis

Annualized DuPont ROE was 8.4%, decomposed into a 7.1% net profit margin, 0.747x asset turnover and 1.58x financial leverage. The dominant improvement was margin-led rather than leverage-led: operating margin rose 480bp year on year to 11.4%, while the net margin expanded 440bp to 7.1%. Gross margin increased 400bp to 27.2%, and SG&A growth of 7.0% was below sales growth of 11.8%, demonstrating positive operating leverage. Basic Materials produced the most important profit inflection, turning from a ¥3.4bn loss to a ¥5.7bn profit; its segment margin was 4.5% on ¥124.8bn of external sales. Value-added Materials was the core business by operating-income contribution, generating ¥8.2bn of segment profit, up 109.1%, on revenue of ¥42.9bn, up 13.9%; its segment margin was 19.1%. Water Treatment Engineering generated ¥6.6bn of segment profit on revenue of ¥42.0bn, with a 15.6% margin, although profit fell 8.7% year on year. Bioscience delivered the highest segment margin at 37.2%, with profit up 24.0% to ¥5.7bn on essentially flat revenue of ¥15.4bn. High-performance Materials recorded revenue growth of 13.8% to ¥34.3bn and profit growth of 29.1% to ¥3.2bn, lifting margin to 9.2%. Other operations generated ¥1.9bn of profit, up 45.2%, on ¥14.8bn of sales. Non-operating income was ¥4.7bn, or 1.7% of revenue, and therefore does not dominate reported profitability; foreign-exchange gains of ¥1.67bn nevertheless contributed to the ordinary-income outperformance. The tax burden measured against profit attributable to owners was 0.586, implying an effective burden of about 41.4%, which reduced conversion of pre-tax earnings into owner earnings. The reported 33.8% effective tax rate based on consolidated net income including non-controlling interests is less severe, but owner-level earnings conversion remains an item to monitor. Interest coverage was strong at 22.71x on EBIT and 31.82x on EBITDA, limiting current interest-cost pressure. The quarterly earnings profile therefore reflects genuine operating-margin recovery, but sustainable return improvement requires higher asset efficiency and cash realization rather than further balance-sheet leverage.

Growth Assessment

Revenue growth of 11.8% was broad-based across all reported operating segments. Basic Materials sales increased 11.7% to ¥124.8bn, Value-added Materials increased 13.9% to ¥42.9bn, High-performance Materials increased 13.8% to ¥34.3bn, Water Treatment Engineering increased 11.1% to ¥42.0bn, and Other operations increased 18.6% to ¥14.8bn. Bioscience revenue was nearly unchanged, up 0.2% to ¥15.4bn, although its profit improved 24.0%, suggesting improved profitability rather than volume-led growth. The Basic Materials turnaround is important because it is the largest revenue business, but its 4.5% segment margin remains below those of the specialty-oriented businesses. Value-added Materials and Bioscience provide the most attractive current segment economics, with margins of 19.1% and 37.2%, respectively. The decline in Water Treatment Engineering profit despite revenue growth indicates that not all growth is converting into margins equally. Full-year guidance calls for sales of ¥1,170.0bn, up 14.7%, operating income of ¥105.0bn, up 9.9%, ordinary income of ¥107.0bn, up 0.2%, and owner-attributable profit of ¥59.0bn. Q1 sales progress is 23.4% versus a standard 25%, only 1.6 percentage points below the benchmark. Q1 operating-income progress is 29.7%, 4.7 percentage points above the benchmark, while ordinary-income progress is 32.1% and owner-profit progress is 33.0%. Thus, the outlook embeds a slower profit run-rate in the remaining quarters than in Q1, particularly below ordinary income, consistent with potential normalization of foreign exchange and other non-operating contributions. The forecast revision indicates management has updated its outlook, while the unchanged dividend forecast suggests that shareholder distributions have not been raised alongside the revised earnings outlook.

Financial Health

Liquidity is sound, with a current ratio of 213.1%, a quick ratio of 173.4%, and working capital of ¥443.4bn. Cash and deposits of ¥191.4bn slightly exceeded short-term loans of ¥186.1bn, producing a cash-to-short-term-debt ratio of 1.03x. This cash coverage reduces immediate refinancing pressure, but it is narrow given that 66.0% of interest-bearing debt is short term. Total interest-bearing debt was ¥282.1bn, comprising ¥186.1bn of short-term loans and ¥96.0bn of long-term loans. Short-term loans increased ¥41.4bn year on year, or 28.6%, and financing cash flow was driven by a ¥36.3bn net increase in short-term loans. Long-term loans also increased ¥11.8bn year on year to ¥96.0bn. Debt-to-equity was a manageable 0.58x, debt-to-capital was 23.3%, and total liabilities represented 36.8% of assets, indicating a generally conservative capital structure. However, Debt/EBITDA was 6.46x on the reported quarterly EBITDA basis, above the 4.0x high-leverage alert threshold and a key credit-risk metric to monitor. This elevated figure must be viewed alongside very strong interest coverage, but it makes continued earnings and cash-flow recovery important. Current assets of ¥835.4bn substantially exceeded current liabilities of ¥391.9bn, so there is no current-ratio or near-term maturity mismatch warning. Property, plant and equipment rose ¥10.9bn year on year to ¥434.7bn and represented 29.6% of total assets, consistent with a capital-intensive chemical manufacturing base. Accounts receivable increased ¥11.9bn to ¥292.2bn and inventories increased ¥7.6bn to ¥155.9bn, tying a larger portion of the balance sheet to the operating cycle. Investment securities increased ¥6.0bn to ¥86.5bn, while accumulated other comprehensive income rose to ¥79.4bn, supported by valuation and currency translation movements. Net defined-benefit liabilities were ¥18.8bn and should remain part of the assessment of long-duration obligations.

Notable B/S Changes

Short-term loans: +¥41.4bn (+28.6%) to ¥186.1bn - principal source of Q1 financing inflow; raises refinancing dependence because short-term debt represents 66.0% of total interest-bearing debt. Long-term loans: +¥11.8bn (+14.0%) to ¥96.0bn - adds to gross debt while cash flow remains constrained by working-capital investment. Accounts receivable: +¥11.9bn (+4.3%) to ¥292.2bn - contributes to weak operating cash conversion and is consistent with elevated 97-day DSO. Inventories: +¥7.6bn (+5.1%) to ¥155.9bn - working-capital absorption and elevated inventory-day alerts increase exposure to demand and valuation risk. Property, plant and equipment: +¥10.9bn (+2.6%) to ¥434.7bn - maintains a substantial capital-intensive manufacturing base and accompanies ¥16.6bn of Q1 non-current-asset purchases. Investment securities: +¥6.0bn (+7.4%) to ¥86.5bn - increases market-value and other-comprehensive-income sensitivity within equity.

Cash Flow Quality

Cash-flow quality was weak in FY2027 Q1 despite the sharp accounting earnings recovery. Operating cash flow was only ¥0.4bn, compared with ¥19.5bn of profit attributable to owners, resulting in an OCF/net-income ratio of 0.02x and triggering the earnings-quality alert. Cash conversion, measured as operating cash flow divided by EBITDA, was 0.01x versus EBITDA of ¥43.7bn, also well below the 0.7x caution threshold. The primary cause was working-capital absorption: trade receivables and contract assets increased by ¥13.1bn, while inventories increased by ¥10.7bn. Income-tax payments of ¥16.8bn further reduced operating cash flow. Trade payables increased only ¥0.7bn and did not offset the receivables and inventory build. Receivable days were 97 days, above the 60-day warning level, indicating slow cash collection relative to annualized sales. Inventory days were flagged at 116 days under the broader working-capital calculation and at 71 days under the inventory-specific calculation; both point to inventory intensity above applicable efficiency benchmarks. The cash conversion cycle was 163 days, well above the 120-day warning threshold, exposing cash generation to demand, pricing and inventory-valuation movements. Within reported inventory categories, finished goods were ¥155.9bn, raw materials were ¥79.1bn, and work in process was ¥19.7bn; the sizeable finished-goods balance makes sales execution and potential inventory valuation central monitoring items. Investing cash flow was negative ¥20.0bn, including ¥16.6bn of purchases of non-current assets. Free cash flow was negative ¥19.6bn, so internally generated Q1 cash did not cover investment spending. Financing cash flow of ¥31.6bn, principally short-term debt expansion, funded the cash shortfall and supported a ¥13.6bn increase in cash. The low OCF/earnings conversion is a material concern rather than evidence of permanent impairment in profitability, because the disclosed drivers are identifiable working-capital and tax outflows; nevertheless, improvement in receivable collection and inventory normalization is necessary to validate earnings quality.

Dividend Sustainability

The full-year dividend forecast is ¥100 per share, unchanged despite the forecast revision. Based on forecast EPS of ¥191.63, the implied dividend payout ratio is approximately 52.2%, within the sub-60% range generally viewed as sustainable. The forecast dividend represents an improvement from the ¥50 per share prior-period dividend disclosed for the comparable quarter, although quarterly dividend timing should not be interpreted as the full-year payment pattern. Earnings coverage is therefore adequate on the stated full-year forecast. Cash-flow coverage is weaker in Q1: operating cash flow was ¥0.4bn and free cash flow was negative ¥19.6bn, while cash dividends paid were ¥15.4bn. Consequently, near-term distribution funding was not covered by Q1 internally generated free cash flow and coincided with greater short-term borrowing. Balance-sheet liquidity and a 0.58x debt-to-equity ratio provide capacity to sustain the stated dividend in the near term. However, durable dividend capacity depends on operating cash flow recovering toward reported earnings as receivables and inventories normalize. The unchanged dividend forecast suggests management is retaining flexibility while the operating recovery and cash conversion are tested through subsequent quarters.

Risk Assessment

Business risks include Chemical-cycle and product-spread risk: Basic Materials returned to profit, but its 4.5% segment margin remains modest and could reverse if selling prices, feedstock costs or industry supply-demand conditions deteriorate., Specialty-business execution risk: Water Treatment Engineering profit fell 8.7% year on year despite 11.1% revenue growth, indicating potential cost, project-mix or execution pressure in a major profit contributor., Working-capital and inventory risk: receivable days of 97, inventory days flagged at 116 and 71 under respective calculations, and a 163-day cash conversion cycle increase exposure to slower customer demand, collection delays and inventory valuation losses., Foreign-exchange risk: Q1 ordinary income benefited from a ¥1.67bn FX gain, compared with an FX loss in the prior-year quarter; this contribution may not recur and can introduce earnings volatility., Chemical-industry regulatory and environmental risk: a large manufacturing asset base requires continuing compliance with safety, emissions, waste-management and site-remediation standards, with potential cost escalation or operational disruption..

Financial risks include High leverage alert: Debt/EBITDA was 6.46x, above the 4.0x alert threshold. Although interest coverage remains strong, a weaker earnings cycle could reduce deleveraging capacity., Refinancing risk: 66.0% of debt is short term, and short-term loans increased 28.6% year on year to ¥186.1bn. Cash covers short-term loans only narrowly at 1.03x., Cash-conversion risk: OCF/net income of 0.02x and OCF/EBITDA of 0.01x show that current accounting earnings have not yet translated into cash., Capital-expenditure funding risk: free cash flow was negative ¥19.6bn after ¥16.6bn of non-current-asset purchases, causing reliance on financing inflows during the quarter..

Key concerns include Highest priority: convert the Q1 profit rebound into operating cash flow by reducing receivable and inventory intensity., High priority: limit reliance on short-term debt funding and demonstrate that the Q1 increase in borrowings is temporary rather than structural., Moderate priority: sustain the Basic Materials turnaround through a potentially volatile chemical cycle., Moderate priority: restore Water Treatment Engineering profit growth while preserving its relatively high 15.6% segment margin., Moderate priority: monitor the owner-level tax burden of approximately 41.4%, which constrained net-income conversion from pre-tax earnings..

Investment Implications

Key takeaways include Q1 operating income nearly doubled to ¥31.2bn, with operating margin improving to 11.4% from 6.6%., The earnings recovery was broad based, with the Basic Materials loss turning into a ¥5.7bn profit and Value-added Materials profit rising 109.1% to ¥8.2bn., Value-added Materials is the core business by segment operating-income contribution and combines strong growth with a 19.1% segment margin., Q1 operating-profit progress of 29.7% is ahead of the 25% seasonal benchmark for the ¥105.0bn full-year forecast., Reported earnings quality is the key offset: only ¥0.4bn of operating cash flow was generated against ¥19.5bn of owner-attributable profit., Balance-sheet liquidity is strong, but the Q1 cash deficit was financed largely through higher short-term borrowing..

Metrics to watch include Operating cash flow, OCF/net income ratio and OCF/EBITDA cash conversion., Receivable days, inventory days and the cash conversion cycle., Short-term loans, cash-to-short-term-debt ratio and Debt/EBITDA., Basic Materials segment margin and the durability of its return to profitability., Water Treatment Engineering segment profit and margin progression., The extent to which FX gains continue to support ordinary income., Progress against full-year guidance for ¥1,170.0bn sales, ¥105.0bn operating income and ¥59.0bn owner-attributable profit..

Regarding relative positioning, Tosoh's Q1 profile is that of a capital-intensive diversified chemical manufacturer with improving mid-cycle profitability: its 11.4% operating margin is within the good 8-15% benchmark range, its annualized 8.4% ROE is improved but below a strong 10%+ return threshold, and its liquidity and interest coverage are solid. Relative quality is constrained by unusually weak Q1 cash conversion, high working-capital intensity and a debt/EBITDA measure above the high-leverage benchmark. Specialty businesses, particularly Value-added Materials and Bioscience, provide materially superior margins to Basic Materials and underpin the quality of the portfolio.